Financials
- Market Capitalization 437.84 M
- Employee 44
- Founded 2024
- CEO N/A
- Website www.crescentbiopharma.com
- Headquarter Cayman Islands
- FIGI N/A
- Industry 医薬品メーカー(一般)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.12
売上高対価格比率
1.75
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2140 | MAZE Maze Therapeutics, Inc. - Common Stock | 30.21 USD | +3.53% | -9.50% | +24.17% | -32.91% | 1.67 B USD | ||
| 2867 | EIKN Eikon Therapeutics, Inc. - Common Stock | 10.34 USD | -0.96% | -13.04% | +8.61% | -39.35% | 559.79 M USD | ||
| 3120 | UPB Upstream Bio, Inc. - Common Stock | 7.25 USD | -0.41% | -7.76% | +17.12% | -38.56% | 394.54 M USD | ||
| 3151 | QTTB Q32 Bio Inc. - Common Stock | 19.75 USD | -7.62% | +42.50% | +54.54% | +872.91% | 334.89 M USD |